JPMorgan Chase & Co. Has $102.88 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)

JPMorgan Chase & Co. cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,072,266 shares of the company's stock after selling 143,055 shares during the quarter. JPMorgan Chase & Co. owned 1.24% of HealthEquity worth $102,884,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Holocene Advisors LP bought a new position in HealthEquity during the 3rd quarter worth $1,246,000. Pier Capital LLC acquired a new stake in shares of HealthEquity during the 4th quarter worth $8,024,000. HighTower Advisors LLC increased its position in shares of HealthEquity by 4.8% in the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after purchasing an additional 4,370 shares during the period. Geneva Capital Management LLC raised its stake in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock valued at $100,642,000 after purchasing an additional 206,894 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in HealthEquity by 165.7% during the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company's stock worth $1,673,000 after purchasing an additional 12,745 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.20% of the company's stock.

Remove Ads

HealthEquity Trading Down 5.0 %

Shares of NASDAQ:HQY traded down $4.17 during midday trading on Friday, hitting $78.80. 1,933,052 shares of the stock were exchanged, compared to its average volume of 740,684. The business's 50-day moving average price is $101.66 and its 200 day moving average price is $96.21. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 1.60 and a beta of 0.49.

Wall Street Analyst Weigh In

Several research firms have commented on HQY. JMP Securities raised their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group cut their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Finally, KeyCorp dropped their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Monday, March 24th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $112.58.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.